- The Emergent Landscape of Detecting EGFR Mutations Using Circulating Tumor DNA in Lung Cancer
Wei-Lun Huang et al, 2015, BioMed Research International CrossRef - Application of Plasma Genotyping Technologies in Non–Small Cell Lung Cancer: A Practical Review
Adrian G. Sacher et al, 2017, Journal of Thoracic Oncology CrossRef - Can EGFR mutations in plasma or serum be predictive markers of non-small-cell lung cancer? A meta-analysis
Ying Wu et al, 2015, Lung Cancer CrossRef - Diagnostic value of circulating free DNA for the detection of EGFR mutation status in NSCLC: a systematic review and meta-analysis
Jie Luo et al, 2015, Sci Rep CrossRef - Detection EGFR exon 19 status of lung cancer patients by DNA electrochemical biosensor
Xiong-Wei Xu et al, 2016, Biosensors and Bioelectronics CrossRef - Update on EGFR Mutational Testing and the Potential of Noninvasive Liquid Biopsy in Non–Small-cell Lung Cancer
Edward Kim et al, 2017, Clinical Lung Cancer CrossRef - Technologies for analysis of circulating tumour DNA: Progress and promise
Zhen Zou et al, 2017, TrAC Trends in Analytical Chemistry CrossRef - Detection of EGFR mutations in patients with non-small cell lung cancer by high resolution melting. Comparison with other methods
Carlos Martínez-Carretero et al, 2017 CrossRef - Investigation of the epidermal growth factor receptor mutation rate in non-small cell lung cancer patients and the analysis of associated risk factors using logistic regression
QINSHI PAN et al, 2014 CrossRef - Management of acquired resistance to EGFR TKI-targeted therapy in advanced non-small cell lung cancer.
Shang-Gin Wu et al, 2018, Mol Cancer CrossRef - Incorporating blood-based liquid biopsy information into cancer staging: time for a TNMB system?
M Yang et al, 2018 CrossRef - Role of circulating tumor DNA in the management of early-stage lung cancer
Heng Zhao et al, 2018, Thorac Cancer CrossRef - Fundamental Concepts in the Application of Plasma Genotyping (Liquid Biopsy) to EGFR Mutation Detection in Non–Small-Cell Lung Cancer
Adrian G. Sacher, 2018, JCO Precision Oncology CrossRef - A liquid biopsy in primary lung cancer
Kazue Yoneda et al, 2018, Surg Today CrossRef - Evaluation of PCR-HRM, RFLP, and direct sequencing as simple and cost-effective methods to detect common EGFR
mutations in plasma cell-free DNA of non-small cell lung cancer patients
Jamal Zaini et al, 2019, Cancer Reports CrossRef - null
Amin El-Heliebi et al, 2019 CrossRef - Lessons learned from routine, targeted assessment of liquid biopsies for EGFR T790M resistance mutation in patients with EGFR mutant lung cancers
Sebastian Mondaca et al, 2019, Acta Oncologica CrossRef - High Resolution Melting Analysis for Epidermal Growth Factor Receptor Mutations in Formalin-fixed Paraffin-embedded Tissue and Plasma Free DNA from Non-small Cell Lung Cancer Patients
Chang-Wen Jing et al, 2013, Asian Pacific Journal of Cancer Prevention CrossRef - Insufficiency of peripheral blood as a substitute tissue for detecting EGFR mutations in lung cancer: a meta-analysis
Zhijun Li et al, 2014, Targ Oncol CrossRef - Snapback Primer Mediated Clamping PCR for Detection ofEGFRandKRASMutations in NSCLC Patients by High Resolution Melting Analysis
Haiyan Sun et al, 2014, BioMed Research International CrossRef - Detection of EGFR mutations in plasma and biopsies from non-small cell lung cancer patients by allele-specific PCR assays
Britta Weber et al, 2014, BMC Cancer CrossRef - Direct assessment of cytochrome P450 2D6 genotypes by high-resolution melting analysis and DNA sequencing
Ya-Sian Chang et al, 2014, Environmental Toxicology and Pharmacology CrossRef - Emerging platforms using liquid biopsy to detectEGFRmutations in lung cancer
Chien-Chung Lin et al, 2015, Expert Review of Molecular Diagnostics CrossRef - Role of circulating-tumor DNA analysis in non-small cell lung cancer
Tao Jiang et al, 2015, Lung Cancer CrossRef - Comparison of next generation sequencing, SNaPshot assay and real-time polymerase chain reaction for lung adenocarcinoma EGFR mutation assessment
Andrei-Tudor Cernomaz et al, 2016, BMC Pulm Med CrossRef - Neueste technologische Entwicklungen für die Analyse von zirkulierender Tumor-DNA
Peter Ulz et al, 2016, medgen CrossRef - null
Samantha Perakis et al, 2017 CrossRef - EGFR T790M ctDNA testing platforms and their role as companion diagnostics: Correlation with clinical outcomes to EGFR-TKIs
Zhiyong Liang et al, 2017, Cancer Letters CrossRef - Establishing PNB-qPCR for quantifying minimal ctDNA concentrations during tumour resection
T. Ehlert et al, 2017, Sci Rep CrossRef - A multiple signal amplification electrochemical biosensors based on target DNA recycling for detection of the EGFR mutation status in lung cancer patients
Xiu-Hua Weng et al, 2019, Journal of Electroanalytical Chemistry CrossRef - Can peripheral blood be used as surrogate in detecting epidermal growth factor receptor mutation status in advanced non-small cell lung cancer patients? A meta-analysis
Xiaowei Mao et al, 2017, Oncotarget CrossRef - Circulating cell-free DNA has a high degree of specificity to detect exon 19 deletions and the single-point substitution mutation L858R in non-small cell lung cancer
Xin Qian et al, 2016, Oncotarget CrossRef - Molecular Evolution Patterns in Metastatic Lymph Nodes Reflect the Differential Treatment Response of Advanced Primary Lung Cancer
Sang-Won Um et al, 2016, Cancer Res CrossRef - Circulating Tumor DNA Is Effective for the Detection of EGFR Mutation in Non–Small Cell Lung Cancer: A Meta-analysis
Mantang Qiu et al, 2015, Cancer Epidemiol Biomarkers Prev CrossRef - Limitations in the Use of Serum Epidermal Growth Factor Receptor Mutations as Prognostic Markers for Non-Small-Cell Lung Cancer
Yongjun Zhang et al, 2015, Med Princ Pract CrossRef - A multiple detection method for distinguishing gene mutations based on melting curves of extended quenching probes
Wang Jianping et al, 2022, Heliyon CrossRef